AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 114 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 1,666 | -98.4% | 0.00% | – |
| Q1 2022 | $48,000 | -18.6% | 102,766 | 0.0% | 0.00% | – |
| Q4 2021 | $59,000 | -65.5% | 102,766 | -0.4% | 0.00% | – |
| Q3 2021 | $171,000 | -37.1% | 103,138 | -36.7% | 0.00% | – |
| Q2 2021 | $272,000 | +455.1% | 162,900 | +86.2% | 0.00% | – |
| Q1 2019 | $49,000 | +40.0% | 87,500 | 0.0% | 0.00% | – |
| Q4 2018 | $35,000 | -20.5% | 87,500 | 0.0% | 0.00% | – |
| Q3 2018 | $44,000 | -77.2% | 87,500 | 0.0% | 0.00% | – |
| Q2 2018 | $193,000 | +436.1% | 87,500 | +94.9% | 0.00% | – |
| Q1 2017 | $36,000 | -10.0% | 44,901 | +0.0% | 0.00% | – |
| Q4 2016 | $40,000 | +21.2% | 44,900 | 0.0% | 0.00% | – |
| Q3 2016 | $33,000 | -43.1% | 44,900 | 0.0% | 0.00% | – |
| Q2 2016 | $58,000 | -34.8% | 44,900 | +19.7% | 0.00% | – |
| Q2 2015 | $89,000 | – | 37,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |